Cancer Prevention Pharmaceuticals is a company developing therapeutics designed to reduce the risk of cancer and other diseases. Its main product is CPP-1X, that decreases polymine synthesis and in combo therapy with sulindac (CPP-1X/sul) also increases polymine elimination and reduces inflammation which has an important effect on the pathway of several diseases.